Preliminary Study: 3D Nailing for Intertrochanteric Femur Fractures

Weibin Li,Lishan Sun,Yasen Cao
2024-04-26
Abstract:Objective: This study introduced the structural features of the Three-Dimensional Proximal Femoral Nail (3DPFN), a patented invention, and highlights its advantages in treating intertrochanteric fractures of the femur. Furthermore, biomechanical comparative experiments validated the biomechanical performance of 3DPFN in treating Evans-Jensen type IV intertrochanteric fractures. Methods: Evans-Jensen type IV intertrochanteric fracture models were created using artificial femurs produced by the American company Sawbone. From January to April 2022, the experimental group was fixed with 3DPFN, while the control group was fixed with the Proximal Femoral Nail Antirotation (PFNA), simulating the loading conditions in the human body. Axial static ultimate pressure tests and dynamic fatigue tests were conducted. The recorded parameters included the maximum load-bearing capacity under axial load, the maximum number of cycles, and the maximum load before failure. Results: Static ultimate pressure tests showed that the static ultimate load in the 3DPFN group was 2532.67±49.20N, whereas in the PFNA group, it was 2240.00±84.35N, with a significant difference between the two groups (P < .05). Dynamic fatigue tests revealed that the maximum number of cycles in the 3DPFN group was 86372.67±4762.59 cycles, while in the PFNA group, it was 8606.67±606.05 cycles, also showing a significant difference (P < .05). Dynamic fatigue tests further indicated that the fatigue limit load before failure in the 3DPFN group was 1664.00±78.27N, whereas in the PFNA group, it was 799.33±63.52N. Again, there was a significant difference between the two groups (P < .05). Conclusion: In both static compression and fatigue tests, 3DPFN exhibits significant biomechanical advantages over PFNA. This suggests that 3DPFN may be an excellent choice for the treatment of intertrochanteric fractures of the femur and holds further research value for development. Future studies may involve clinical trials to validate and refine the 3DPFN design based on the observed results and promote the advancement of orthopedic implant technology.
What problem does this paper attempt to address?